MBC is a triple-negative breast cancer (progestin receptor, estrogen receptor, and human epidermal growth factor receptor 2) with a very poor prognosis when compared with other types of breast cancers. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.